Discover
ANAB
AnaptysBio, Inc.
45.95
2 x 33.85
2 x 59.16
bid
ask
-
0.26
0.56%
2 @ 07:44 PM
45.76 -0.19 (0.41%)
| Ytd | 42.17% | |
| 1y | 116.95% |
45.81
day range
47.19
20.91
52 week range
69.81
| Open | 46.11 | Prev Close | 46.21 | Low | 45.81 | High | 47.19 | Mkt Cap | 1.37B |
| Vol | 495.67K | Avg Vol | 565.82K | EPS | -0.96 | P/E | N/A | Forward P/E | 9.07 |
| Beta | 0.45 | Short Ratio | 12.32 | Inst. Own | 105.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 54.52 | 200-d Avg | 49.12 | 1yr Est | 87.25 |
| Income Statement | |||
| Total Revenue | 27.49M | ||
| Revenues (USD) | 27.49M | ||
| Gross Profit | 27.49M | ||
| Operating Expenses | -39.47M | ||
| Research and Development Expense | -36.66M | ||
| Selling, General and Administrative Expense | -2.81M | ||
| Operating Income | 66.96M | ||
| Income Tax Expense | -181.49M | ||
| Net Income | 183.88M | ||
| Net Income Common Stock | 183.88M | ||
| Net Income Common Stock (USD) | 183.88M | ||
| Consolidated Income | 183.88M | ||
| Net Income from Discontinued Operations | 45.36M | ||
| Earnings per Basic Share | 6.36 | ||
| Earnings per Basic Share (USD) | 6.36 | ||
| Earnings per Diluted Share | 5.34 | ||
| Earning Before Interest & Taxes (EBIT) | 2.39M | ||
| Earning Before Interest & Taxes (USD) | 2.39M | ||
| Weighted Average Shares | 29.27M | ||
| Weighted Average Shares Diluted | 37.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 133.83M | ||
| Cash and Equivalents (USD) | 133.83M | ||
| Investments | 30.32M | ||
| Investments Current | 30.32M | ||
| Trade and Non-Trade Receivables | 25.63M | ||
| Current Assets | 198.43M | ||
| Property, Plant & Equipment Net | 11.66M | ||
| Total Assets | 316.98M | ||
| Debt Current | 2.16M | ||
| Total Debt | 269.59M | ||
| Current Liabilities | 35.35M | ||
| Debt Non-Current | 267.43M | ||
| Total Liabilities | 306.40M | ||
| Accumulated Retained Earnings (Deficit) | -641.56M | ||
| Accumulated Other Comprehensive Income | -151.00K | ||
| Shareholders Equity | 10.59M | ||
| Shareholders Equity (USD) | 10.59M | ||
| Assets Non-Current | 118.56M | ||
| Total Debt (USD) | 269.59M | ||
| Liabilities Non-Current | 271.05M | ||
| Trade and Non-Trade Payables | 4.39M | ||
| Tax Assets | 106.64M | ||
| Tax Liabilities | 3.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 358.00K | ||
| Net Cash Flow from Financing | -95.56M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -114.64M | ||
| Capital Expenditure | 17.00K | ||
| Issuance (Purchase) of Equity Shares | 11.35M | ||
| Issuance (Repayment) of Debt Securities | -6.91M | ||
| Net Cash Flow from Investing | 7.56M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.55M | ||
| Net Cash Flow from Operations | -26.64M | ||
| Share Based Compensation | -5.90M | ||